Chronic intermittent hypoxia increases rat sternohyoid muscle NADPH oxidase expression with attendant modest oxidative stress by Robert Williams et al.
ORIGINAL RESEARCH ARTICLE
published: 30 January 2015
doi: 10.3389/fphys.2015.00015
Chronic intermittent hypoxia increases rat sternohyoid
muscle NADPH oxidase expression with attendant modest
oxidative stress
Robert Williams1, Paul Lemaire1, Philip Lewis1, Fiona B. McDonald2, Eric Lucking2, Sean Hogan1,
David Sheehan3, Vincent Healy1 and Ken D. O’Halloran1*
1 Department of Physiology, School of Medicine, University College Cork, Cork, Ireland
2 School of Medicine and Medical Science, University College Dublin, Dublin, Ireland
3 School of Biochemistry and Cell Biology, University College Cork, Cork, Ireland
Edited by:
Brian McDonagh, University of
Liverpool, UK
Reviewed by:
Nazareno Paolocci, Johns Hopkins
University, USA
Cecilia Hidalgo, Universidad de
Chile, Chile
*Correspondence:
Ken D. O’Halloran, Department of
Physiology, School of Medicine,
University College Cork, 3-079,
Western Gateway Building, Western
Road, Cork, Ireland
e-mail: k.ohalloran@ucc.ie
Chronic intermittent hypoxia (CIH) causes upper airway muscle dysfunction. We
hypothesized that the superoxide generating NADPH oxidase (NOX) is upregulated in
CIH-exposed muscle causing oxidative stress. Adult male Wistar rats were exposed
to intermittent hypoxia (5% O2 at the nadir for 90 s followed by 210 s of normoxia),
for 8 h per day for 14 days. The effect of CIH exposure on the expression of NOX
subunits, total myosin and 4-hydroxynonenal (4-HNE) protein adducts in sternohyoid
muscle was determined by western blotting and densitometry. Sternohyoid protein free
thiol and carbonyl group contents were determined by 1D electrophoresis using specific
fluorophore probes. Aconitase and glutathione reductase activities were measured as
indices of oxidative stress. HIF-1α content and key oxidative and glycolytic enzyme
activities were determined. Contractile properties of sternohyoid muscle were determined
ex vivo in the absence and presence of apocynin (putative NOX inhibitor). We observed
an increase in NOX 2 and p47 phox expression in CIH-exposed sternohyoid muscle
with decreased aconitase and glutathione reductase activities. There was no evidence,
however, of increased lipid peroxidation or protein oxidation in CIH-exposed muscle. CIH
exposure did not affect sternohyoid HIF-1α content or aldolase, lactate dehydrogenase,
or glyceraldehyde-3-phosphate dehydrogenase activities. Citrate synthase activity was
also unaffected by CIH exposure. Apocynin significantly increased sternohyoid force
and power. We conclude that CIH exposure upregulates NOX expression in rat
sternohyoid muscle with concomitant modest oxidative stress but it does not result
in a HIF-1α-dependent increase in glycolytic enzyme activity. Constitutive NOX activity
decreases sternohyoid force and power. Our results implicate NOX-dependent reactive
oxygen species in CIH-induced upper airway muscle dysfunction which likely relates to
redox modulation of key regulatory proteins in excitation-contraction coupling.
Keywords: apocynin, intermittent hypoxia, NADPH oxidase, oxidative stress, respiratory muscle, sternohyoid,
sleep apnea, upper airway
INTRODUCTION
Obstructive sleep apnea syndrome (OSAS) is a debilitating oxida-
tive stress disorder (Lavie, 2003) which is very common. OSAS
is associated with a wide spectrum of co-morbidities includ-
ing cardiovascular, metabolic and neurocognitive dysfunction
(Verstraeten, 2007; Lévy et al., 2009). Chronic intermittent
hypoxia (CIH) is a central dominant feature of OSAS, and there is
now convincing evidence from animal models that CIH recapitu-
lates many of the hallmark features of the disorder. Upper airway
(UA) muscle dysfunction is implicated in the pathophysiology of
OSAS. OSAS patients (Carrera et al., 1999) and the English bull-
dog (Petrof et al., 1994), an animal model of OSAS, show signs
of UA dilator muscle remodeling, dysfunction and damage. CIH
alters UA muscle function (McGuire et al., 2002; Liu et al., 2005;
Pae et al., 2005; Dunleavy et al., 2008; Ding and Liu, 2011; Skelly
et al., 2012a) and induces UA muscle structural remodeling in
some (McGuire et al., 2002; Pae et al., 2005) but not all (Ray et al.,
2007; Skelly et al., 2012a) studies.
CIH exposure is typically associated with an increased pro-
duction of reactive oxygen species (ROS) (Prabhakar, 2001;
Peng and Prabhakar, 2003; Yuan et al., 2004; Shan et al.,
2007; Dunleavy et al., 2008; Dutta et al., 2008; Raghuraman
et al., 2009; Sharma et al., 2009; Khan et al., 2011) which
can contribute to the development of skeletal muscle dysfunc-
tion (Dunleavy et al., 2008; Dutta et al., 2008; Jackson, 2008;
Ding and Liu, 2011; Skelly et al., 2012a; Shortt et al., 2014).
Pro-oxidants exacerbate (Dunleavy et al., 2008), while antioxi-
dant strategies ameliorate (Dunleavy et al., 2008; Skelly et al.,
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2012a; Shortt et al., 2014) CIH-induced respiratory muscle dys-
function. Moreover, superoxide scavengers increase sternohyoid
muscle force (Skelly et al., 2010, 2012b) highlighting that basal
ROS production is inhibitory to UA muscle function. These
observations highlight that ROS are important modulators of
respiratory muscle performance under physiological and patho-
physiological conditions. Although it is well established that
CIH increases ROS production, the source of ROS is less clear.
CIH-induced oxidative stress in the liver (Jun et al., 2008), car-
diovascular system (Nisbet et al., 2009), and brain (Hui-guo
et al., 2010) is ameliorated by the inhibition of NADPH oxidase
(NOX) activity suggesting that this membrane-bound superox-
ide generating enzyme is a major source of CIH-induced ROS.
In skeletal muscle fibers, NOXs are localized to the sarcoplas-
mic reticulum (Xia et al., 2003), transverse tubules (Hidalgo
et al., 2006), and plasma membranes (Javesghani et al., 2002);
inhibition of NOXs in skeletal muscle reduces the levels of super-
oxide (Javesghani et al., 2002; Patwell et al., 2004). We recently
reported that CIH-induced diaphragm dysfunction in the rat
is blocked by chronic supplementation with the putative NOX
inhibitor—apocynin (Shortt et al., 2014). Together, these stud-
ies implicate a role for NOX-derived ROS in skeletal muscle (dys)
function.
We sought to determine the effects of CIH on the expression
levels of NOX proteins in rat sternohyoid muscle (a representative
UA dilator critical in the control of airway caliber) and to establish
whether or not CIH alters the redox status of the sternohyoid. In
functional studies of sternohyoid muscle ex vivo, we explored the
effects of apocynin on isometric and isotonic contractile proper-
ties. We postulated that CIH upregulates NOX expression in rat
sternohyoid muscle resulting in oxidative stress and that NOX-
dependent ROS exert an inhibitory effect on sternohyoid force-
and power-generating capacity.
MATERIALS AND METHODS
ETHICAL APPROVAL
All procedures involving animals were performed under license
from the Irish Government Department of Health and Children
and were carried out in accordance with National and European
guidelines, following approval from University College Dublin
Animal Research Ethics Committee.
CHRONIC INTERMITTENT HYPOXIA
Adult male Wistar rats were exposed to sham or chronic inter-
mittent hypoxia (CIH) exposure. Rats were housed as normal
in standard cages placed within commercially designed environ-
mental chambers (Oxycyler™, Biospherix, USA) for daily gas
treatments. Ambient oxygen was servo-controlled to generate
intermittent hypoxia: 90 s hypoxia (5% O2 at the nadir) and 210 s
normoxia (21% O2), 12 cycles per hour, 8 h per day for 14 con-
secutive days. A rodent pulse oximeter (Mouse Ox™ Starr Life
Sciences Corp., USA) was used to determine the resulting arterial
oxygen saturation (SaO2) during CIH exposure; SaO2 decreased
to ∼70–80% at the nadir of the recurrent hypoxic events. On the
day following gas treatments, animals were euthanized humanely
(cervical spinal transection under 5% isoflurane anesthesia) and
the sternohyoid muscles were excised.
TISSUE PREPARATION
Muscles were homogenized (GLH Homogeniser Omni
International) in RIPA lysis buffer (25mM Tris-HCl pH
7.6, 150mM sodium chloride, 1% NP-40, 1% sodium deoxy-
cholate, 0.1% SDS) supplemented with protease inhibitor cocktail
(1mM AEBSF, 800μM aprotinin, 40μM bestatin, 14μM E-64,
20μM leupeptin, 15μM pepstatin A; Sigma Aldrich, Ireland)
and phosphatase inhibitors 10mM sodium fluoride, 1mM
sodium orthovanadate, using a 10% w/v ratio. Samples were
homogenized using 8 × 10 s bursts and left on ice for 20min.
Homogenates were then centrifuged for 15min at 11,000 g and
the supernatants were stored at −80◦C. Protein concentration
was determined using a bicinchoninic (BCA) assay (Thermo
Scientific, Ireland) as described in the manufacturer’s protocol
with absorbances measured at 562 nm using a SpectraMax-M3
spectrophotometer (Molecular Devices, USA).
WESTERN BLOTTING
Protein samples were mixed with an equal volume of 2x
laemmli buffer (4% sodium dodecyl sulfate (SDS), 10%
β-mercaptoethanol, 20% glycerol, 0.004% bromophenol blue,
0.125M Tris-HCl, pH 6.8) and 15μg of protein from each sam-
ple was resolved on 7.5 and 12.5% SDS-polyacrylamide gels
depending on the protein. Resolved proteins were then elec-
trophoretically transferred onto nitrocellulose membranes (Bio-
Rad, Hercules, CA). Membranes were incubated in 0.1% (w/v)
Ponceau S in 5% acetic acid to reversibly stain the transferred
proteins to assess equal protein loading and transfer, and were
digitally photographed for densitometric analysis. The mem-
branes were blocked for 1 h in TBST (20mM Tris-HCl, pH 7.6,
150mM NaCl, 0.1% Tween) containing 5% non-fat dried milk
and were incubated overnight with the primary antibody specific
for the protein of interest as follows: anti-NOX 2 and anti-p47
phox, 1:1000 (BD Biosciences, UK); anti-p22 phox, 1:1000 (Santa
Cruz, USA); anti-4-HNE, 1:2000 (Millipore, Ireland).
Membranes were incubated for 1 h at room temperature with
a 1:2000 dilution of HRP-linked anti-rabbit or anti-mouse sec-
ondary antibody (Cell Signaling Technology, USA) in 5% non-fat
dried milk/TBST depending on the primary antibody of inter-
est. Bands were visualized using enhanced chemiluminescence
(ECL Plus, GE Healthcare, UK) and exposure to chemilumines-
cent sensitive film (Kodak, USA). Films were developed, digitally
photographed and densitometric analysis of bands of interest was
performed (QuantityOne, Biorad). Band intensities of proteins
of interest were normalized to the intensities of the correspond-
ing Ponceau S staining proteins which were also measured by
densitometric analysis to adjust for protein loading, allowing
comparative analysis between sham and CIH-exposed muscles.
PROTEIN FREE THIOL AND CARBONYL GROUP CONTENT
Muscle homogenates were incubated with either 2mM iodoac-
etamidofluorescein (IAF) or 2mM fluorescein-thiosemicarbazide
(FTSC) (Sigma-Aldrich Co., Ireland) for 2 h in the dark on ice
for detection of protein free thiol and carbonyl groups, respec-
tively. Samples were then precipitated with 20% trichloroacetic
acid (TCA) in acetone, followed by centrifugation at 11,000 g at
4◦C for 3min. Protein pellets were then washed with ice-cold
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excess 1:1 ethylacetate/ethanol or acetone (for FTSC and IAF
respectively) to remove excess TCA, interfering salts and non-
protein contaminants. Samples were dried, re-suspended in sam-
ple buffer containing 5% β-mercaptoethanol and heated at 95◦C
for 5min before 1D electrophoretic separation on a 12% poly-
acrylamide gel. Fluorescent images of the gels were captured on
a Typhoon Trio+ Variable-Mode Imager (GE Healthcare, UK).
Protein bands were visualized by colloidal coomassie staining
and images were captured on a calibrating image densitometer
(GS-800, Bio-Rad, USA).
HIF-1α AND METABOLIC ENZYME ACTIVITIES
Sternohyoid HIF-1α content was assayed by an immuno-linked
luminescence assay in accordance with manufacturer’s instruc-
tions (Mesoscale Discovery, Gaithersburg, USA). HeLa cells
treated with and without cobalt chloride for 16 h provided pos-
itive and negative controls respectively for the HIF-1α assay.
Aconitase activity was measured using a colorimetric reaction
in accordance with the manufacturer’s instructions (Abcam,
Cambridge, UK). Aconitase is a TCA cycle enzyme that cat-
alyzes the isomerisation of citrate to isocitrate. Isocitrate, in
this assay, undergoes further biochemical reaction resulting in a
product that converts a nearly colorless probe into an intensely
colored form with a peak absorbance at 450 nm. Samples were
incubated in an activating solution containing cysteine-HCl
and (NH4)2Fe(SO4)2on ice for 1 h before addition to a 96-
well plate in duplicate along with isocitrate standards. One
half of the duplicate wells received the sample reaction mix-
ture (containing assay buffer, enzyme mix and substrate) and
the other half the background mixture (containing assay buffer
and enzyme mix only) and samples were incubated for 60min
at 25◦C. Developer was then added to each well and samples
were incubated for a further 10min. Absorbance was measured
at 450 nm and background was subtracted from the test sam-
ple. One unit of aconitase activity is the amount of enzyme
that will isomerize 1mmoles of isocitrate per minute at pH
7.4 and 25◦C. Fructose-1, 6-bisphosphate Aldolase A (aldolase)
is the isoform of the enzyme found predominantly in skele-
tal muscle. It is the 4th enzyme of the glycolysis pathway
which catalyzes the conversion of fructose-1-6-bisphosphate into
both 3-phosphoglyceraldehyde and dihydroxyacetone phosphate.
We developed an assay based upon Boyer’s modification of
the hydrazine assay where 3-phosphoglyceraldehyde reacts with
hydrazine to form a hydrazone which absorbs at 240 nm. 4mM
fructose-1,6-bisphosphate (pH 7.5) (25% v/v), 0.03mM EDTA
pH 7.5 (25% v/v), and 2.3mM hydrazine sulfate (25% v/v)
were added to a 96-well plate and absorbance was recorded
for 10min. Samples and a dH2O blank (25% v/v) were then
added to the plate and absorbance was recorded for another
10min. Using the linear portions of the curve, the A240/min
of the blank was subtracted from the A240/min of the test.
One unit is described as a change in absorbance of 1.00 per
minute at 25◦C and pH 7.5. For GAPDH activity measure-
ment, samples were added to 13.5mM sodium pyrophosphate
buffer (pH 8.5) containing 30mM sodium arsenate, 0.25mM
NAD with 3.325mM DTT. Samples were incubated at 25◦C for
10min to achieve temperature equilibration and to establish a
blank rate, if any. 0.5mM DL-glyceraldehdye-3-phosphate was
added and absorbance was recorded for 10min at 339 nm.
Measured rates were corrected by measuring the blank rate
of the reaction. One unit is defined as 1μmol NADH gener-
ated per minute. Citrate synthase activity was determined using
a commercial kit (Sigma) as per manufacturer’s instructions.
Citrate synthase catalyzes the reaction between acetyl coenzyme
A (acetyl CoA) and oxaloacetic acid (OAA) to form citric acid
and CoA with a thiol group which reacts with DTNB in the
reaction mixture to form 5-thio-nitrobemzoic acid (TNB) which
is absorbed at 412 nm. One unit causes the synthesis of one
micromole of citrate per minute permg protein at 25◦C and
pH 7.5.
MUSCLE PHYSIOLOGY
Adult male Wistar rats were anesthetized with 5% isoflurane
by inhalation in oxygen and killed by cervical spinal transec-
tion. Sternohyoid muscles were excised and longitudinal bundles
were suspended vertically with fine (non-elastic) string; one end
of each strip was mounted to tissue holders, while the other
end was tied firmly to a hook, which sat on a dual-mode force
transducer allowing assessment of isometric and isotonic prop-
erties. The muscle fiber bundles affixed to the tissue holders
were then suspended in standard water-jacketed tissue baths.
The tissue baths were filled with Krebs salt solution, maintained
at 35◦C and bubbled with 95% O2 and 5% CO2. The Krebs
solution contained: 120mM NaCl, 25mM NaHCO3, 12mM
MgSO4, 1.2mM NaH2PO4, 2.5mM CaGluconate, 5mM KCl,
and 11.5mM Glucose. D-tubocurarine (25μM) was used in all
experiments to exclude any potential involvement of excitation
of intramuscular nerve branches. The muscles were stimulated
using supramaximal square wave constant current stimulators
delivered via two platinum electrodes which flanked the tissue in
the bath. The change in tension was transduced, amplified and
converted from an analog-to-digital signal where it was displayed
and recorded on a computer for later analysis. Optimum muscle
length (Lo) was determined by repeated twitch stimulation while
adjusting the length of the muscle with the micropositioner. The
muscle preparations remained at Lo for the duration of the study.
Studies were conducted in the absence and presence of the puta-
tive NOX inhibitor, apocynin (2mM). Muscle preparations were
allowed to equilibrate for 10min before starting the experimental
protocol.
Protocol
Isometric twitch force and kinetics (contraction time and half-
relaxation time) were determined with the lever arm of the force
transducer set to maximum rigidity (∼500 mN; >100% load).
Next, an isometric tetanic contraction (Fmax) was elicited by
stimulating at 100Hz for 300ms (O’Halloran, 2006; Skelly et al.,
2010, 2012a,b; Shortt et al., 2014). Following a 5min rest period,
concentric contractions were elicited in incremental steps with
varying load (0.1, 1, 5, 10, 15, 20%; % of Fmax) with 1min rest
between each contraction. Muscle length returned to Lo following
each contraction. Shortening (Smax) was determined as the max-
imum distance shortened during contraction. Peak shortening
velocity (Vmax) was determined as distance shortened during the
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initial 30ms of shortening, when velocity is greatest at 0% load.
Mechanical power was determined at each step of the incremental
load step test as the product of force x shortening velocity.
DATA ANALYSIS
Peak specific force (Fmax) was calculated in N/cm2 of mus-
cle cross-sectional area. Cross-sectional area was calculated as
follows: mass (g)/(Lo (cm) × muscle density (g/cm3); muscle
density was estimated to be 1.056 g/cm3. Maximum shortening
(Smax) was calculated as length shortened per optimal length
(L/Lo). Peak shortening velocity (Vmax) was calculated as Lo/s.
Peak mechanical power (Pmax) was calculated as Watts/cm2.
STATISTICAL ANALYSIS
Data are expressed as mean ± SEM. Statistical comparisons were
performed between groups using Student unpaired t-tests, Mann
Whitney U-tests, or Two-Way ANOVA with Bonferroni post-hoc
tests as appropriate using Graph Pad Prism. P < 0.05 was the
criterion for statistical significance in all tests.
RESULTS
EFFECT OF CIH ON STERNOHYOID NOX SUBUNIT AND MYOSIN
EXPRESSION
We postulated that CIH would increase sternohyoid NOX sub-
unit expression. Western blots are shown in Figures 1A,B. CIH
significantly increased NOX 2 (Figures 1A,C) and p47 phox
(Figures 1B,E)—but not p22 phox (Figures 1A,D)—expression
in rat sternohyoid muscle. Total myosin protein content was
unaffected by CIH exposure (not shown).
EFFECT OF CIH ON STERNOHYOID 4-HNE PROTEIN ADDUCT LEVELS
AND PROTEIN FREE THIOL AND CARBONYL GROUP CONTENT
We postulated that CIH would increase lipid peroxidation and
protein oxidation. Western blot with respective Ponceau S stained
gel is shown in Figure 2A. CIH exposure did not affect ster-
nohyoid 4-HNE protein adduct levels (Figure 2B). Representative
fluorescent 1D gels tagging protein free thiols (Figure 2C)
and protein carbonyls (Figure 2E) are shown with respective
coomassie stained gels. CIH exposure did not affect protein free
thiol (Figure 2D) or carbonyl group (Figure 2F) content.
EFFECT OF CIH ON STERNOHYOID MUSCLE ACONITASE AND
GLUTATHIONE REDUCTASE ACTIVITIES
We postulated that CIHwould decrease aconitase and glutathione
reductase activities indicative of oxidative stress. CIH exposure
significantly decreased aconitase (Figure 3A) and glutathione
reductase (Figure 3B) activities.
EFFECT OF CIH ON STERNOHYOID MUSCLE HIF-1α CONTENT AND
OXIDATIVE AND GLYCOLYTIC ENZYME ACTIVITIES
We postulated that CIHwould increase HIF-1α content and cause
a shift from oxidative-to-glycolytic metabolism. CIH exposure
FIGURE 1 | Western blot of NOX subunit expression in the sternohyoid
muscle from sham (S) and chronic intermittent hypoxia (CIH)-exposed
rats. (A) Expression of the catalytic superoxide-generating NOX 2 subunit and
the co-anchoring p22 phox subunit with the corresponding Ponceau S stained
membrane used to normalize protein loading and electro-transfer. MWM =
pre-stained molecular weight markers. (B) Expression of the organizer
subunit, p47 phox with corresponding Ponceau S stained membrane.
Densitometric analysis of NOX subunit band intensities normalized by
densitometric intensities of corresponding Ponceau-S stained proteins
expressed in arbitrary units (a.u.) are shown in (C–E). (C) A near 3-fold
increase in NOX 2 expression was observed in the CIH-exposed group
compared to sham control (∗∗P = 0.002; Student unpaired t-test, n = 4 per
group). (D) No change in the p22 phox subunit expression was observed
(P = 0.884, n = 4 per group). (E) A near 2-fold increase in the p47 phox
subunit expression was observed in the CIH-exposed group compared to
sham control (∗P = 0.014, n = 6 per group). Values are mean ± SEM.
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FIGURE 2 | Western blot of 4-HNE protein adducts and 1D
electrophoresis to determine free thiol and carbonyl group content in
the sternohyoid muscle from sham and chronic intermittent hypoxia
(CIH)-exposed rats. Sham and CIH samples were loaded in alternate lanes
(numbered in the figure). (A) Sternohyoid 4-HNE content together with
Ponceau S stained membrane. (B) Densitometric analysis of 4-HNE protein
adduct band intensities normalized by densitometric intensities of
corresponding Ponceau S stained proteins expressed in arbitrary units (a.u.)
from sham and CIH-exposed rats. No significant difference was observed in
4-HNE protein adduct content (P = 0.9372; Student unpaired t-test)
comparing sham and CIH-exposed sternohyoid muscles. Representative
images of sternohyoid iodoacetamidofluorescein (IAF)-tagged protein free
thiol groups (C) and fluorescein-thiosemicarbazide (FTSC)-tagged carbonyl
groups (E) with corresponding coomassie stained membranes used to
normalize protein loading and electrotransfer. Densitometric analysis of
protein free thiol group (D) and carbonyl group (F) contents normalized by
densitometric intensities of corresponding coomassie stained proteins
expressed in arbitrary units (a.u.) from sham and CIH-exposed rats. Protein
free thiol and carbonyl group content of the sternohyoid muscle was not
significantly different in sham and CIH-exposed rats (P = 0.699 and
P = 0.180 respectively; Student unpaired t-tests). Values are mean ± SEM;
n = 6 per group.
did not affect sternohyoid HIF-1α content (not shown). Similarly,
CIH exposure did not affect citrate synthase (0.23 ± 0.01 vs.
0.22 ± 0.01, mean±SEM, units/mg protein; Student unpaired
t-test: p = 0.518), aldolase (1.90 ± 0.06 vs. 2.00 ± 0.11 units/mg
protein; p = 0.425), lactate dehydrogenase (0.45± 0.08 vs. 0.42±
0.08 units/mg protein; p = 0.805) or glyceraldehyde-3-phosphate
dehydrogenase (0.56 ± 0.12 vs. 0.53 ± 0.09 units/mg protein;
p = 0.845) activities.
EFFECT OF APOCYNIN ON STERNOHYOID MUSCLE CONTRACTILE
PROPERTIES
We postulated that the putative NOX inhibitor—apocynin—
would increase force- and power-generating capacity of the
sternohyoid muscle. Data for sternohyoid muscle contractile
properties are shown in Table 1. Contractile kinetics and twitch
force determined during isometric contractions were unaffected
by apocynin. There was an increase in the maximum velocity
of shortening (Vmax) in apocynin-treated preparations during
isotonic contractions but this did not achieve statistical signifi-
cance (p = 0.095). Maximum muscle shortening during isomet-
ric contractions (Smax) was unaffected by apocynin. Conversely,
apocynin significantly increased sternohyoid muscle peak tetanic
force (Fmax; Figure 4A) determined under isometric conditions
and increased muscle power (force x velocity of shortening;
Figure 4B) over a range of loads (10–20% of Fmax) during
concentric contractions.
DISCUSSION
The key findings of this study are: (1) CIH significantly increased
NOX 2 and p47 phox—but not p22 phox—subunit expression
in rat sternohyoid muscle; (2) CIH did not increase the lev-
els of sternohyoid 4-HNE protein adducts; (3) CIH did not
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FIGURE 3 | Sternohyoid muscle aconitase and glutathione reductase
enzyme activities in sham and chronic intermittent hypoxia
(CIH)-exposed rats. Aconitase (A) and glutathione reductase (B) activities
were significantly decreased in CIH-exposed sternohyoid muscles
compared to sham controls: ∗P = 0329 and ∗∗P = 0.0046; Student
unpaired t-tests. Values are mean ± SEM; n = 8 per group.
Table 1 | Sternohyoid muscle contractile properties in the absence
and presence of 2mM apocynin.
Control Apocynin P-value
CT (ms) 15±1 17±2 0.407a
½RT (ms) 12±1 12±2 0.647a
Pt (N/cm2) 2.5±0.6 2.6±0.2 0.922b
Vmax (Lo/s) 6.5±0.8 8.9±0.7 0.095c
Smax (L/Lo) 0.29±0.02 0.34±0.03 0.129a
Values are mean ± SEM; n = 5 for both groups. CT, isometric contraction time;
½RT, isometric half-relaxation time; Pt, isometric twitch force; Vmax, maximum
shortening velocity under isotonic conditions of zero load normalized to opti-
mum length (Lo); Smax, peak shortening normalized to Lo. Data were compared
using aStudent unpaired t-test, bStudent unpaired t-test with Welch’s correction
or cMann Whitney U-test as appropriate following tests for normality and equal
variances in the data sets.
affect protein free thiol or carbonyl group content in sternohyoid
muscle; (4) CIH decreased aconitase and glutathione reductase
activities indicative of modest oxidative stress; (5) CIH did not
affect HIF-1α content or the activities of citrate synthase, aldolase,
lactate dehydrogenase or glyceraldehyde-3-phosphate dehydroge-
nase; (6) The putative NOX inhibitor—apocynin—significantly
increased sternohyoid force and power.
It is well established in various animal models that CIH
impairs respiratory muscle function (Dunleavy et al., 2008; Skelly
et al., 2010, 2012a; Shortt et al., 2014). We have previously
FIGURE 4 | Sternohyoid muscle isometric and isotonic contractile
properties in the absence and presence of apocynin. (A) Sternohyoid
peak tetanic force (Fmax) determined ex vivo in the absence or presence of
2mM apocynin (putative NOX inhibitor). Fmax was significantly increased in
apocynin-treated muscle preparations (∗P = 0.03; Student unpaired t-test).
(B) Power-load relationship of sternohyoid muscle determined ex vivo in the
absence or presence of 2mM apocynin. Power (force x velocity of
shortening) was significantly increased in apocynin-treated preparations
(P = 0.023 (drug); Two Way repeated measures ANOVA; ∗P < 0.01
Bonferroni post-hoc test). Values are mean ± SEM; n = 5 per group.
reported sternohyoid muscle weakness in adult male Wistar rats,
an effect that was ameliorated by chronic tempol (a superox-
ide scavenger) supplementation (Skelly et al., 2012a) implicating
ROS in CIH-induced muscle dysfunction. A variety of sources of
ROS have been described but the major contributing source in
CIH-induced UA muscle dysfunction has yet to be determined. A
number of models have identified the NOX complex as a potential
source of ROS contributing to redox modulation and/or oxida-
tive injury (Pigeolet et al., 1990; Berry et al., 2000; Ozaki et al.,
2000; Javesghani et al., 2002; Hidalgo et al., 2006; Nair et al., 2011;
Shortt et al., 2014). Xia et al. (2003) identified a much higher
rate of superoxide production per milligram of protein in the sar-
coplasmic reticulum compared to the mitochondria in muscle. In
view of these studies and our previous work (Skelly et al., 2010,
2012a,b), we sought to investigate NOX as a potential source of
ROS in CIH-exposed UA muscle.
The present study shows that CIH exposure increased key
NOX subunits in sternohyoid muscle. We observed a near 3-fold
increase in the catalytic subunit—NOX 2—and a near 2-fold
increase in the organizer subunit—p47 phox. There is a body of
research that implicates hypoxia as a driving force underpinning
enhanced NOX expression and activity in various tissues. Acute
repetitive hypoxia was shown to increase NOX activity ∼12-fold
in the carotid body (Peng et al., 2009). This increase in activity was
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associated with an increase in NOX mRNA and protein expres-
sion. CIH was also shown to increase NOX 2 protein and mRNA
expression in PC12 pheochromocytoma cells as well as mouse
embryonic fibroblasts mediated through hypoxia inducible factor
1 (HIF-1) (Yuan et al., 2011). Similarly, Souvannakitti et al. (2010)
showed that CIH increases NOX 2 activity and mRNA expression
in adrenal medullae of neonatal rats. Recent work by Zhou et al.
(2012) examined the effects of different CIH paradigms, report-
ing time- and intensity-dependent increases in rat myocardial p22
phox mRNA expression. Extending this line of enquiry, ours is
the first study to our knowledge to report an increase in NOX 2
and p47 phox protein subunits in CIH-exposed UA respiratory
muscle and this appears to be independent of HIF-1α activation.
We acknowledge, however, that the exact site(s) of NOX subunit
upregulation is not known and it could extend to the muscle vas-
culature; this is a limitation of the experimental approach taken
in the present study.
Animal models of CIHmost often report evidence of increased
oxidative stress in various tissues, consistent with the observa-
tion that human OSAS is an oxidative stress disorder (Lavie,
2003). Despite reporting a significant increase in NOX subunit
expression in CIH-exposed sternohyoid muscle, we did not detect
overt oxidative stress in the tissue, assessed by measurement of
protein free thiol and carbonyl group content. This was further
corroborated by assessment of the levels of 4-HNE (a highly reac-
tive lipid peroxidation product and initiator of oxidative stress)
which was unchanged in the CIH-exposed airway dilator muscle.
On the face of it, the apparent lack of oxidative stress following
CIH is surprising given our previous findings that antioxidant
supplementation ameliorates or prevents CIH-induced respira-
tory muscle dysfunction (Dunleavy et al., 2008; Skelly et al.,
2012a; Shortt et al., 2014). Of note however, CIH-induced ster-
nohyoid muscle dysfunction is reversible by acute antioxidant
treatment following CIH exposure (Skelly et al., 2012a). The latter
observation strongly suggests that CIH exposure does not cause
irreversible oxidative modification (damage) to muscle, consis-
tent with the lack of evidence of increased protein carbonylation
in CIH-exposed muscle reported in the present study. Rather,
CIH-induced sternohyoid muscle weakness (Skelly et al., 2012a)
appears to be a dynamic ROS-dependent process that is entirely
reversible, which is important in the context of potential antiox-
idant pharmacotherapy for human OSAS. Of note, CIH was
associated with significant decreases in aconitase and glutathione
reductase activities highlighting the development of a modest
oxidative stress in CIH-exposed muscle.
In view of the collective data described above, we specu-
late that CIH-induced sternohyoid dysfunction (Skelly et al.,
2012a) is mediated by altered redox signaling, perhaps within
microdomains of the muscle, evidently with no widespread cel-
lular stress. A number of groups have reported localization of the
NOX subunit complex, or at least some components, to areas near
the sarcoplasmic reticulum and transverse tubules of muscle (Xia
et al., 2003; Hidalgo et al., 2006; Sun et al., 2011). Oxidation of
redox-sensitive cysteine residues in these microdomains affects
calcium release through ryanodine receptor channels (Hidalgo
et al., 2006; Sun et al., 2011); Ca2+ release is promoted during
low level ROS turnover but is inhibited during high level ROS
production (Geiszt et al., 1997; Kawakami and Okabe, 1998; Reid,
2001). Thus, it is plausible to suggest that CIH-induced NOX-
dependent elevated ROS might impair muscle force-generating
capacity without concomitant widespread oxidative stress/injury.
CIH-induced oxidative damage has been observed in skeletal
muscle (Dutta et al., 2008) and other tissues (Veasey et al., 2004;
Raghuraman et al., 2009; Khan et al., 2011). It appears that the
detrimental effects of CIH manifest in a “dose”-dependent man-
ner and the effects of oxidative stress may be organ-specific (Shan
et al., 2007; Jun et al., 2008). It is worth noting that the experimen-
tal paradigm of CIH used in our studies is relatively modest and
based on the observations of Raghuraman et al. (2009), that short
bouts of IH (15 s hypoxia; 5min normoxia) produce higher levels
of ROS compared to 90 s hypoxic/normoxic cycles, our paradigm
might not be expected to produce severe oxidative stress per se.
To explore the potential for NOX-dependent ROS to modu-
late sternohyoid muscle performance, we examined the effects of
apocynin on sternohyoid muscle contractile properties. Apocynin
significantly increased isometric sternohyoid peak force revealing
that basal NOX-derived ROS exert a powerful inhibitory influence
on sternohyoid contractile performance. This finding is consis-
tent with a previous study by our group highlighting that super-
oxide scavengers are powerful inotropic agents (Skelly et al., 2010,
2012a), extending this work to suggest that NOX is an impor-
tant source of basal ROS production in rat sternohyoid muscle.
Of note, apocynin did not affect isometric contractile kinetics
although an increase in the maximum velocity of shortening
under isotonic conditions was observed. This failed to achieve
statistical significance but the increase likely contributed to the
increase in power-generating capacity observed in apocynin-
treated preparations. The greater power-generating capacity of
the sternohyoid over physiological loads (predominantly due to
increased force-generating capacity) translates in vivo to a greater
capacity to preserve and maintain UA caliber, given that the ster-
nohyoid is a recognized UA dilator muscle. Our data highlight
that ROS are powerful inhibitors of sternohyoid force and power,
and by extension we posit that increased ROS associated with CIH
(or other stimuli including enhanced muscle activity) impairs
sternohyoid muscle function. The significance of our findings,
in concert with our previous study (Skelly et al., 2012a), is that
CIH exposure—a dominant feature of human sleep-disordered
breathing—is detrimental to the control of UA caliber, poten-
tially increasing the risk of obstructive airway events. In this
regard, CIH exposure could establish an inescapable cycle serv-
ing to exacerbate and perpetuate respiratory morbidity in human
OSAS.
It is plausible to suggest that NOX-derived ROS could affect
contractile function through actions at one or more sites critical
in the excitation-contraction coupling mechanism (Geiszt et al.,
1997; Kawakami and Okabe, 1998; Reid, 2001; Hidalgo et al.,
2006; van der Poel et al., 2007; Lamb and Westerblad, 2011; Sun
et al., 2011). It is likely that ROS downstream of superoxide,
such as hydrogen peroxide, affect sternohyoid muscle perfor-
mance (Shortt and O’Halloran, 2014). We speculate that the
inotropic effects of apocynin relate to redox modulation of cal-
cium sensitivity of the contractile filaments (Edwards et al., 2007;
Murphy et al., 2008). Collectively, the data are consistent with the
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widely held view that ROS are important signaling molecules in
the context of skeletal muscle function. By extension, we postu-
late that increased NOX-derived ROS production following CIH
exposure is likely responsible for sternohyoid muscle weakness
(Skelly et al., 2012a), given that ROS are inhibitory to sternohyoid
force (this study; Skelly et al., 2010, 2012a,b).
In summary, we have previously shown that CIH exposure
causes upper airway dilator muscle weakness, an effect which is
blocked by chronic antioxidant supplementation. Here we report
that CIH exposure results in increased sternohyoid muscle NOX 2
and p47 phox subunit expression with attendantmodest oxidative
stress. Apocynin significantly enhanced sternohyoidmuscle force-
and power-generating capacity. Our results implicate NOX as a
potential source of ROS which exert substantial inhibitory effects
on sternohyoid muscle performance. We speculate that CIH-
induced muscle dysfunction relates to NOX-dependent redox
modulation within specificmyocellular microdomains relevant to
contractile function. The results are further supportive of our pre-
vious contention that antioxidant treatment may serve as a useful
adjunctive therapy in human OSAS.
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